Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen

Technology appraisal guidance
Reference number: TA259
Published: 27 June 2012
Last updated: 27 July 2016

Response to consultee, commentator and public comments on the Appraisal consultation document

Response to consultee, commentator and public comments on the Appraisal consultation document

Response to consultee, commentator and public comments on the Appraisal consultation document
18 May 2012
(220.45 Kb 4 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 18 May 2012